Kineticos Senior Team Decades of Experience, Trusted Knowledge
At Kineticos, our senior team consists of life sciences industry professionals with decades of combined experience and highly-diversified backgrounds. With a wealth of knowledge gained from this extensive life science experience, Kineticos delivers significant value to a range of clients seeking trusted strategy consulting services. Below, you will find information and details about the backgrounds, education, and industry experience of our leadership team members.
Mr. Maingi founded Kineticos Life Sciences in 2012 and develops long-term and day-to-day execution strategies.
In addition to serving as CEO of Kineticos, Mr. Maingi is as a Board Observer for Locus BioSciences, a CRISPR gene editing start-up. Mr. Maingi also served on the Board of Directors at Gallus Biopharmaceutical, a biopharmaceutical CMO, and on the Advisory Boards of Novolipid and Enci Therapeutics, two pre-clinical oncology biotechnology start-ups. Mr. Maingi is currently on the Board of Directors at Prevention Partners, a Chapel Hill, NC based non-profit. In addition, Mr. Maingi is Adjunct Faculty at the UNC’s Kenan-Flagler School of Business.
Prior to founding Kineticos Life Sciences, Mr. Maingi was a senior executive at Cardinal Health/PTS and Sigma-Aldrich/Supelco. Mr. Maingi earned a BS in Chemistry from UNC, Chapel Hill and an MBA from Golden Gate University.
Mr. Maingi’s Areas of Expertise:
Corporate Strategy and Execution
Research and Innovation
Business and Corporate Development
Process Improvement / Change Management
Mr. Finger serves as Executive Vice President and Managing Director of Kineticos’ Precision Medicine and Diagnostics practice and brings over 25 years of diagnostic and laboratory experience to the firm. Prior to joining Kineticos in 2012, Mr. Finger served as the Global Director of Technical Services and Sales Operations at LabCorp Clinical Trials and was responsible for supporting internal customers (sales, operations, companion diagnostics and lab) and external customers (pharma, biotech, and CROs) with both technical and commercial strategies to help support clinical trials. While at LabCorp, Mr. Finger had oversight of Technical Services / Scientific Affairs to include technical lab support and pricing, sales operations, and LIMS globally across the LabCorp network of labs and also managed the preclinical lab, specimen management, and construction of the biorepository. Prior to joining LabCorp, Mr. Finger held various roles of increasing responsibility at Champlain Valley Physicians’ Hospital, Duke University Medical Center and Wake Health Services.
Mr. Finger earned his Masters of Healthcare Administration from UNC-Chapel Hill and a BS in Medical Technology from the State University of New York at Plattsburgh.
Mr. Finger’s Areas of Expertise:
Mr. Buckanavage serves as the Managing Director of Kineticos’ Biopharmaceutical Practice and adds over 30 years of commercial experience in the pharmaceutical and biotech industry having successfully launched products in the US, Europe, and Japan.
Most recently, Steve held senior commercial positions at Celyad, assisting the Belgium based cell & gene therapy company through a successful US IPO, establishing US operations in Boston, staffing key roles and running operations. Prior to joining Celyad, Mr. Buckanavage was the VP of Commercial Strategy at GSK’s Cancer Immunotherapy Business Unit where he was responsible for the commercial strategy for the antigen specific cancer immunotherapy portfolio. Prior to that, Steve spent over 15 years at AstraZeneca in various roles. He was the US Commercial Head for franchises such as cardiovascular, anesthesia, and infectious disease having launched brands in all three categories. His time at AstraZeneca also included serving as the Global VP of Emerging Oncology responsible for a portfolio of small molecule and biologic assets.
Mr. Buckanavage’s Areas of Expertise:
Mr. Hampton brings over 10 years of operational and commercial of experience to the firm.
Mr. Hampton is responsible for managing the sales and execution of client engagements within Kineticos’ Biopharmaceutical practice. Prior to being appointed Managing Director of the Biopharmaceutical practice, Mr. Hampton established and drove Kineticos’ Marketing initiatives, which included robust branding/awareness, lead generation and thought leadership programs. Additionally, Mr. Hampton played an integral role during Kineticos’ early years by establishing finance, human resources, and project management processes.
Mr. Hampton earned his BS degree in Business Management with a Finance concentration from North Carolina State University.
Mr. Hampton’s Areas of Expertise:
Business Development and Licensing
Key Opinion Leader Engagement
Sales and Marketing
Mr. Osterman, Senior Vice President of Kineticos’ Biopharmaceutical Practice, adds more than 25 years of experience in the biopharmaceutical industry to the team.
Mr. Osterman held roles in sales, clinical, and marketing at GlaxoSmithKline before moving to Johnson & Johnson, where he launched their stem cell internal venture and was responsible for the cardiovascular, pulmonary, metabolic, and mimetibody therapeutic areas in the Global Biologic Strategic Marketing. Mr. Osterman then served as Senior Vice President responsible for commercial operations and business development at Discovery Labs before accepting a position as Vice President of Global Marketing at Solstice Neurosciences. Immediately prior to joining Kineticos, he founded the Osterman Strategy Group, a boutique management consulting firm, where he worked with large and emerging biopharmaceutical companies to help solve their most challenging business issues.
Mr. Osterman earned a dual BA in Business Management and Economics from North Carolina State University.
Mr. Osterman’s Areas of Expertise:
Global Strategic Marketing
New Business Development
Merger and Acquisition Strategy
Organizational and Leadership Development
Mr. Dupere brings 30 years of experience in the biopharmaceutical industry to the Kineticos team. He spent 10 years immersed in formative training across core disciplines including clinical research, regulatory affairs, project, communications, and product management at both medical device (CTL, Inc.) and pharmaceuticals (Burroughs Wellcome Co.). He then started ATOM, Inc., a boutique consultancy focused on helping companies–including Lilly, Genentech, Sanofi and others—project manage the commercial launch their first oncology product. Mr. Dupere progressed to start new business units as Vice President of Business Development at LifeMetrix, retained consultant at US Oncology (Market Focus), and Sr. Vice President, Oncology Biopharmaceutical Solutions at Biologics, Inc. More recently, as COO for QOL Medical, he successfully re-positioned and built out an orphan disease company.
Mr. Dupere earned his BS in Public Health and MBA, both from the University of North Carolina at Chapel Hill.
Mr. Dupere’s Areas of Expertise:
Product Opportunity Assessment
Patient Access and Optimization
Contact Us Today to Discover How We Can Elevate Your Business Our Strategy Consulting Services Are Designed to Enhance Your Value